Bridgefront Capital, LLC Perkinelmer Inc Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	3,067 New	3,067 $371,000
Q4 2023 Feb 14, 2024	BUY	N/A	1,911 New	1,911 $231,000
Q3 2022 Nov 29, 2022	BUY	$118.07 - $160.96 $402,736 - $549,034	3,411 New	3,411 $410,000
Q2 2021 Aug 12, 2021	SELL	$127.81 - $155.84 $226,479 - $276,148	-1,772 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$120.35 - $160.53 $213,260 - $284,459	1,772 New	1,772 $227,000

575

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.